RightBio Metrics

RightBio Metrics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $4.5M

Overview

RightBio Metrics is a private diagnostics company addressing a critical patient safety issue: the dangerous misplacement of NG/OG tubes. Its core innovation is the RightSpotpH® Indicator, a closed-system device that offers immediate, clear pH readings to confirm gastric placement, positioning itself as a superior alternative to unreliable auscultation (the 'whoosh test') and traditional pH paper. The company is commercial-stage, FDA-cleared, and CLIA-waived, targeting widespread adoption in hospitals to reduce X-ray reliance, lower costs, and prevent patient harm, including aspiration pneumonia and death.

Patient SafetyCritical CareGastroenterology

Technology Platform

Closed-system, in-line pH indicator device for immediate visual verification of nasogastric/orogastric tube placement. Designed for clarity, contamination prevention, and workflow integration.

Funding History

1
Total raised:$4.5M
Seed$4.5M

Opportunities

Significant opportunity to displace the outdated and high-risk 'whoosh test' (auscultation), still used in over 70% of U.S.
hospitals according to the company.
Growing alignment with global patient safety initiatives and major nursing organizations creates a powerful tailwind for evidence-based practice change and product adoption.

Risk Factors

Market adoption is slowed by the need to change deeply entrenched clinical protocols and hospital policies.
Faces competition from the entrenched, zero-cost practice of auscultation and low-cost pH paper, requiring continuous proof of superior clinical and economic value.

Competitive Landscape

Primary competition is the current standard of care: unreliable auscultation and traditional pH paper strips. RightSpotpH® competes by offering greater accuracy, speed, and safety (closed system) versus paper, and by providing an objective, evidence-based alternative to the discredited auscultation method. Potential for new entrants with alternative verification technologies exists.